Skip to main content

Month: April 2020

Onex to Acquire Independent Clinical Services

 All amounts in U.S. dollars unless otherwise stated TORONTO, April 16, 2020 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) and its affiliated funds today announced that it has agreed to acquire Independent Clinical Services Group Ltd. (“ICS”) in partnership with the existing management team and with a reinvestment in the equity by the former majority shareholder, TowerBrook Capital Partners LP.  ICS is a leading specialised staffing, workforce management solutions, and health and social services business operating primarily in Europe and present across four continents globally.  ICS’s 1,850 employees serve over 2,000 clients from offices in 10 countries. The transaction is expected to close later this year, subject to customary conditions and regulatory approvals.  The terms of the transaction are not being disclosed.“ICS...

Continue reading

Reed’s Inc. Prices Underwritten Public Offering of Common Stock

NORWALK, Conn., April 16, 2020 (GLOBE NEWSWIRE) — Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock at a price of $0.375 per share for gross proceeds of approximately $5.0 million. Reed’s has also granted to the underwriter a 45-day option to purchase an additional 2,000,000 shares of common stock to cover overallotments in connection with the offering. The offering is expected to close on April 20, 2020, subject to customary closing conditions.Roth Capital Partners is acting as the sole manager for the offering.Reed’s intends to use the net proceeds from the proposed offering to fund working capital and for general corporate purposes.A shelf registration statement relating...

Continue reading

CDW Provides Business Updates on Impact of COVID-19

LINCOLNSHIRE, Ill., April 16, 2020 (GLOBE NEWSWIRE) — CDW Corporation (Nasdaq:CDW) today announced updates related to the novel coronavirus, COVID-19.“Our mission at CDW is to help our customers navigate change and be successful in an ever-evolving world.  This mission is even more relevant during the current COVID-19 crisis,” said Christine A. Leahy, chief executive officer, CDW. “First quarter demand was strong as customers looked to CDW to meet urgent needs for greater technology capabilities.  CDW teams have worked tirelessly to safeguard the health and well-being of each other and to continue delivering for our customers at this time of great need.”“Given the depth and duration of the pandemic is unknown, it is too early to predict the full impact of COVID-19 on our business.  We are committed to deliver on our mission by providing...

Continue reading

Rellevate Joins Cardtronics’ Allpoint Network To Provide ATM Access

HOUSTON, April 16, 2020 (GLOBE NEWSWIRE) — Rellevate, LLC, a digital banking fintech company aimed at facilitating consumers’ access, movement, and use of their money-anytime, anywhere, has teamed with Cardtronics to provide surcharge-free cash access through Cardtronics’ Allpoint Network.Rellevate customers can withdraw cash at over 55,000 Allpoint ATMs worldwide using their Rellevate Visa® Debit Card, avoiding costly ATM surcharge fees.“Whether it’s digital banking, saving, paying bills, moving money, accessing earned pay between payroll cycles, or obtaining cash, our mission is to offer access to consumer financial services at fair, affordable prices,” said Stewart Stockdale, Chairman and CEO of Rellevate. “By offering convenient and worldwide   access to cash through its extensive Allpoint Network, Cardtronics makes an ideal...

Continue reading

Truxton Corporation Announces Quarterly Cash Dividend

NASHVILLE, Tenn., April 16, 2020 (GLOBE NEWSWIRE) — Truxton Corporation (OTCPK: TRUX), a financial holding company and the parent of Truxton Trust Company, announced that its Board of Directors has approved a quarterly cash dividend of $0.28 per common share payable June 26, 2020, to shareholders of record as of June 10, 2020.About Truxton TrustTruxton Trust Company is a provider of private banking, wealth management, trust, and family office services for wealthy individuals, their families and their business interests.  Serving clients across the world, Truxton’s vastly experienced team of professionals provides customized solutions to its clients’ complex financial needs.  Founded in 2004 in Nashville, Tennessee, Truxton Trust upholds its original guiding principle: do the right thing. Truxton Trust Company is a subsidiary of...

Continue reading

Truxton Corporation Reports First Quarter 2020 Results

NASHVILLE, Tenn., April 16, 2020 (GLOBE NEWSWIRE) — Truxton Corporation, the parent company for Truxton Trust Company (“Truxton” or “the Bank”) and subsidiaries, announced its operating results for the quarter ended March 31, 2020.  First quarter net income attributable to common shareholders was $2.5 million or $0.87 per share compared to $2.2 million or $0.78 per share for the same quarter in 2019.  Net income rose by 13% for the quarter while earnings per share rose by 12%.“We are very pleased with results in the first quarter, reflecting the dedication and hard work of the Truxton team,” stated Chairman and CEO Tom Stumb.  “By the end of the quarter, however, our country was facing an unprecedented public health crisis, dramatically reducing economic activity.  Truxton has taken extensive measures to protect the health of our...

Continue reading

OptimizeRx Sets First Quarter 2020 Conference Call for Monday, May 4, 2020 at 4:30 p.m. ET

ROCHESTER, Mich., April 16, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Monday, May 4, 2020 at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2020. The financial results will be issued in a press release prior to the call.OptimizeRx management will host the call, followed by a question and answer period.Date: Monday May 4, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-800-458-4148International dial-in number: 1-323-794-2597Conference ID: 2817301Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference...

Continue reading

PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial

Expanded infectious disease program to address current and potential pandemics builds on existing tuberculosis collaborationInitiation of Phase 2 VERSATILE-002 trial for PDS0101 in advanced/metastatic head and neck cancer delayed due to global COVID-19 pandemicPRINCETON, N.J., April 16, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced an expanded infectious disease pandemic development program, including novel vaccines for COVID-19 and universal influenza, in addition to its previously announced tuberculosis development collaboration with Farmacore Biotechnology. The Company also announced that initiation of its multi-center...

Continue reading

AMMO, Inc. Expands Distribution Network with Rollout of Product Offerings to Additional Retail Locations Nationwide

SCOTTSDALE, Ariz., April 16, 2020 (GLOBE NEWSWIRE) — AMMO, Inc. (OTCQB: POWW) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, announced the rollout of its full portfolio of loaded ammunition, including its STREAK™ Visual Ammunition, brass casings and munition components, to an additional 201 retail stores in the first 15 days of the quarter throughout the U.S. Included in the rollout were 150 Rural King and Murdoch’s Ranch & Home Supply locations.“The significant increase in demand across the commercial market has allowed us to further expand AMMO’s distribution footprint throughout the U.S.,” said Fred Wagenhals, AMMO’s CEO. “Adding distribution is critical to building our brand in the industry, and I am confident we will continue to grow our U.S. and international...

Continue reading

FluroTech Partners With Albany Medical College For the Potential Development of a COVID-19 Diagnostic Test

CALGARY, Alberta, April 16, 2020 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) is pleased to announce that it has entered into a strategic Agreement in Principle with Alberta BioPhotonics Inc. (“ABP”) and Albany Medical College (“AMC”) to form FluroTest LLC (“FluroTest”).The CompleTest™ adaptation is expected to take approximately three months with trials planned shortly thereafter. We caution that FluroTest is taking the existing technology developed by FluroTech and adapting that technology to be able to test for COVID-19. We are still in the early stages of research and development and are not making any express or implied claims that it can accurately diagnose COVID-19 virus at this time. FluroTech and ABP are majority shareholders in FluroTest.The collaboration will have primary focus on adapting FluroTech’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.